Does INVESTIGATIONAL PRODUCT Cause Hyperglycaemia? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Hyperglycaemia have been filed in association with INVESTIGATIONAL PRODUCT. This represents 0.8% of all adverse event reports for INVESTIGATIONAL PRODUCT.
45
Reports of Hyperglycaemia with INVESTIGATIONAL PRODUCT
0.8%
of all INVESTIGATIONAL PRODUCT reports
0
Deaths
28
Hospitalizations
How Dangerous Is Hyperglycaemia From INVESTIGATIONAL PRODUCT?
Of the 45 reports, 28 (62.2%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INVESTIGATIONAL PRODUCT. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does INVESTIGATIONAL PRODUCT Cause?
Febrile neutropenia (241)
Pneumonia (229)
Acute kidney injury (198)
Pyrexia (189)
Anaemia (176)
Diarrhoea (170)
Sepsis (168)
Dyspnoea (156)
Nausea (134)
Hypotension (130)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which INVESTIGATIONAL PRODUCT Alternatives Have Lower Hyperglycaemia Risk?
INVESTIGATIONAL PRODUCT vs INVOKANA
INVESTIGATIONAL PRODUCT vs IOBENGUANE I-131
INVESTIGATIONAL PRODUCT vs IOBITRIDOL
INVESTIGATIONAL PRODUCT vs IODINE
INVESTIGATIONAL PRODUCT vs IODINE\IOFLUPANE I-123